These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8204504)
61. Therapeutic implications of antisense oligonucleotides. Lattuada D; Mazzei M; Meazza R; Nicolin A Int J Clin Lab Res; 1992; 21(4):296-9. PubMed ID: 1591383 [TBL] [Abstract][Full Text] [Related]
62. Episomal expression of a hammerhead ribozyme directed against plum pox virus. Liu B; Tabler M; Tsagris M Virus Res; 2000 Jun; 68(1):15-23. PubMed ID: 10930659 [TBL] [Abstract][Full Text] [Related]
63. Biological and functional aspects of catalytic RNAs. Castanotto D; Rossi JJ; Deshler JO Crit Rev Eukaryot Gene Expr; 1992; 2(4):331-57. PubMed ID: 1486242 [TBL] [Abstract][Full Text] [Related]
65. [Antisense RNA for urokinase receptor inhibits the invasiveness and metastasis of lung carcinoma]. Liao J; Xu S; Tang H; Lian F; Zhu Y Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):357-60. PubMed ID: 11769733 [TBL] [Abstract][Full Text] [Related]
66. Antisense strategies: functions and applications in immunology. Varga LV; Tóth S; Novák I; Falus A Immunol Lett; 1999 Aug; 69(2):217-24. PubMed ID: 10482355 [TBL] [Abstract][Full Text] [Related]
67. Anticubilin antisense RNA ameliorates adriamycin-induced tubulointerstitial injury in experimental rats. Liu J; Li K; He Y; Zhang J; Wang H; Yang J; Zhan J; Liang H Am J Med Sci; 2011 Dec; 342(6):494-502. PubMed ID: 22108171 [TBL] [Abstract][Full Text] [Related]
68. Killing the messenger. Winkler KE Nat Rev Drug Discov; 2004 Oct; 3(10):823-4. PubMed ID: 15599992 [No Abstract] [Full Text] [Related]
69. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies. Jen KY; Gewirtz AM Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915 [TBL] [Abstract][Full Text] [Related]
70. New targets for cancer therapy. Coombes RC Mol Aspects Med; 1993; 14(5):373-449. PubMed ID: 8208067 [No Abstract] [Full Text] [Related]
71. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter. He Y; Huang L Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284 [TBL] [Abstract][Full Text] [Related]
72. Ribozymes expressed within the loop of a natural antisense RNA form functional transcription terminators. Deshler JO; Li H; Rossi JJ; Castanotto D Gene; 1995 Mar; 155(1):35-43. PubMed ID: 7698665 [TBL] [Abstract][Full Text] [Related]
73. Therapeutic antisense and ribozymes. Rossi JJ Br Med Bull; 1995 Jan; 51(1):217-25. PubMed ID: 7767645 [TBL] [Abstract][Full Text] [Related]
77. Anti-CMV drug trials back on-line. GMHC Treat Issues; 1996 May; 10(5):9. PubMed ID: 11363587 [TBL] [Abstract][Full Text] [Related]
78. Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review). Resnicoff M Int J Mol Med; 1998 May; 1(5):883-8. PubMed ID: 9852311 [TBL] [Abstract][Full Text] [Related]
79. [Current view on the anti-hepatitis B therapy]. Guan P; Wang W Zhonghua Yi Xue Za Zhi; 1991 Apr; 71(4):234-8. PubMed ID: 1713808 [No Abstract] [Full Text] [Related]
80. Crystal structure and improved antisense properties of 2'-O-(2-methoxyethyl)-RNA. Teplova M; Minasov G; Tereshko V; Inamati GB; Cook PD; Manoharan M; Egli M Nat Struct Biol; 1999 Jun; 6(6):535-9. PubMed ID: 10360355 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]